摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-3-(7-amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-4-methyl-2-pentenenitrile | 1218924-57-2

中文名称
——
中文别名
——
英文名称
(Z)-3-(7-amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-4-methyl-2-pentenenitrile
英文别名
(Z)-3-(7-aminotriazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-4-methylpent-2-enenitrile
(Z)-3-(7-amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-4-methyl-2-pentenenitrile化学式
CAS
1218924-57-2
化学式
C10H11N7O
mdl
——
分子量
245.244
InChiKey
VWBMREDQYIHBDO-UTCJRWHESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.9
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    127
  • 氢给体数:
    2
  • 氢受体数:
    7

反应信息

  • 作为产物:
    描述:
    8-氮杂腺嘌呤3-hydroxy-3-methyl-1-cyano-1-butynepotassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 1.0h, 以35.5%的产率得到(Z)-3-(7-amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-4-methyl-2-pentenenitrile
    参考文献:
    名称:
    Chemo-, regio- and stereospecific addition of adenine and 8-azaadenine to α,β-acetylenic γ-hydroxy nitriles: a short-cut to novel acyclic adenosine analogues
    摘要:
    Adenine (9H-purin-6-amine) adds readily to available alpha,beta-acetylenic gamma-hydroxy nitriles under mild conditions (molar ratio 1 1, K2CO3, DMF, rt, 10 min) to afford chemo-, regio- and stereospecifically (Z)-3-(6-amino-9H-purin-9-yl)-4-hydroxy-4-alkyl-2-alkenenitriles novel functionalized acyclic nucleoside analogues (95-98% yield) Under similar conditions (K2CO3, DMF, rt, 1 h), 8-azaadenine (3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine) reacts with 4-hydroxy-4-methyl-2-pentynenitrile nonselectively at the 7-, 8- and 9-positions to give the corresponding adducts in a 1 10 5 9 ratio, the total yield being 81% Chemo-, regio- and stereospecific addiction of 8-azaadenine to the above alpha,beta,-acetylenic gamma-hydroxy nitriles leading to (Z)-3-(7-amino-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-4-hydroxy-4-alkyl-2-alkenenitriles in 44-90% yield is attained when the reaction is carried Out without solvent in the presence Of Et3N (30 mol%), the molar ratio of 8-azaadenine alpha,beta-acetylenic nitriles being 1 2 0 (rt, 12-38 h) (C) 2010 Elsevier Ltd All rights reserved
    DOI:
    10.1016/j.tet.2010.01.015
点击查看最新优质反应信息

文献信息

  • Chemo-, regio- and stereospecific addition of adenine and 8-azaadenine to α,β-acetylenic γ-hydroxy nitriles: a short-cut to novel acyclic adenosine analogues
    作者:Boris A. Trofimov、Anastasiya G. Mal'kina、Valentina V. Nosyreva、Olesya A. Shemyakina、Angela P. Borisova、Lyudmila I. Larina、Olga N. Kazheva、Grigorii G. Alexandrov、Oleg A. Dyachenko
    DOI:10.1016/j.tet.2010.01.015
    日期:2010.2
    Adenine (9H-purin-6-amine) adds readily to available alpha,beta-acetylenic gamma-hydroxy nitriles under mild conditions (molar ratio 1 1, K2CO3, DMF, rt, 10 min) to afford chemo-, regio- and stereospecifically (Z)-3-(6-amino-9H-purin-9-yl)-4-hydroxy-4-alkyl-2-alkenenitriles novel functionalized acyclic nucleoside analogues (95-98% yield) Under similar conditions (K2CO3, DMF, rt, 1 h), 8-azaadenine (3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine) reacts with 4-hydroxy-4-methyl-2-pentynenitrile nonselectively at the 7-, 8- and 9-positions to give the corresponding adducts in a 1 10 5 9 ratio, the total yield being 81% Chemo-, regio- and stereospecific addiction of 8-azaadenine to the above alpha,beta,-acetylenic gamma-hydroxy nitriles leading to (Z)-3-(7-amino-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-4-hydroxy-4-alkyl-2-alkenenitriles in 44-90% yield is attained when the reaction is carried Out without solvent in the presence Of Et3N (30 mol%), the molar ratio of 8-azaadenine alpha,beta-acetylenic nitriles being 1 2 0 (rt, 12-38 h) (C) 2010 Elsevier Ltd All rights reserved
查看更多

同类化合物

阿扎次黄嘌呤 钠2-氨基-6-甲基-[1,2,4]三唑并[1,5-a]嘧啶-5-醇 替格瑞洛 曲匹地尔 异亚丙基替卡格雷 布美地尔 唑嘧菌胺 唑嘧磺草胺 去羟基乙氧基替格雷洛 化合物 T15173 v-三唑并[4,5-d]嘧啶,(3H),3-环戊基-7-偏基硫代- [[[3-(4,7-二氢-7-氧代-1H-1,2,3-三唑并[4,5-d]嘧啶-5-基)-4-丙氧基苯基]氨基]亚甲基]丙二酸二乙酯 [1,2,4]噻唑并[1,5-c]嘧啶-5(6h)-酮 [1,2,4]三氮唑并[1,5-A]嘧啶-2-胺 [1,2,4]三唑并[3,4-f]嘧啶 [1,2,4]三唑并[1,5-A]嘧啶-2-羧酸甲酯 [1,2,4]三唑并[1,5-A]嘧啶-2-羧酸 [1,2,4]三唑[1,5,A]嘧啶-7-氨基 [(1R,3S)-3-(5-氨基-7-氯-3H-[1,2,3]三唑并[4,5-d]嘧啶-3-基)环戊基]甲醇 [(1R,3S)-3-(5,7-二氨基-3H-[1,2,3]三唑并[4,5-d]嘧啶-3-基)环戊基]甲醇 N-甲基-1H-1,2,3-三唑并[4,5-d]嘧啶-7-胺 N-(4'-氟丁酰苯)-4-(4-氯苯基)吡啶正离子 N-(2,6-二氯苯基)-5,7-二甲基[1,2,4]三唑并[1,5-a]嘧啶-2-磺酰胺 N-(2,6-二氯-3-甲苯基)-5,7-二甲氧基-[1,2,4]三唑[1,5-a]嘧啶-2-磺酰胺 N-(2,6-二氯-3-甲基苯基)-5,7-二氯-1,2,4-三唑并[1,5-a]吡啶-2-磺酰胺 N-(1,5,6,7-四氢-3,6-二甲基-5,7-二氧代-1,2,4-三唑并[4,3-c]嘧啶-8-基)-乙酰胺 EED抑制剂(EEDINHIBITOR-1) 9H-7,8-二氢-(1,2,3)三唑并(4',5'-4,5)嘧啶并(6,1-b)(1,3)噻嗪-5(3H)-酮 9-乙基-2,4,7,8,9-五氮杂双环[4.3.0]壬-1,3,5,7-四烯-3,5-二胺 8-甲氧基-3-甲基-[1,2,4]三唑并[4,3-C]嘧啶 8-甲基-1,3,7,9-四氮杂双环[4.3.0]壬-2,4,6,8-四烯 8-溴-[1,2,4]三唑并[4,3-c]嘧啶 8-溴-5-(甲硫基)[1,2,4]三唑并[4,3-c]嘧啶 8-氮鸟嘌呤 8-氮杂黄嘌呤 8-氮杂腺嘌呤 8-氮杂-2,6-二氨基嘌呤硫酸盐 8-乙氧基-5-甲氧基[1,2,4]三唑并[1,5-c]嘧啶-2-胺 8-乙基-4-甲基-1,3,7,9-四氮杂双环[4.3.0]壬-2,4,6,8-四烯 7H-[1,2,3]三唑并[4,5-d]嘧啶 7-(2-呋喃基)[1,2,4]三唑并[1,5-a]嘧啶-2-基胺 7-羟基-5-甲基-2(甲硫基)-1,2,4-三唑并[1,5-a]嘧啶-6-羧酸乙酯 7-羟基-5-甲基-1,3,4-三氮吲哚利嗪 7-甲基[1,2,4]三唑并[4,3-A]嘧啶-3-羧酸 7-甲基[1,2,4]三唑并[1,5-a]嘧啶-5-醇 7-甲基-[1,2,4]噻唑并[4,3-c]嘧啶 7-甲基-8-丙基-[1,2,4]噻唑并[1,5-c]嘧啶 7-环丙基[1,2,4]三唑[1,5-a]嘧啶-2-胺 7-氯-[1,2,4]噻唑并[1,5-c]嘧啶 7-氯-[1,2,4]噻唑并[1,5-a]嘧啶